アジア太平洋地域の体外診断市場は、2022年の191億918万ドルから2030年までに309億4327万ドルに成長すると予想され、2022年から2030年までのCAGRは6.2%と推定されます。
アジア太平洋地域の体外診断市場は、中国、日本、インド、オーストラリア、韓国、およびその他のアジア太平洋地域に分割されています。中国での市場の成長は、病気の診断に対する意識の高まりに起因しています。インドは国全体で病気が蔓延しているため、体外診断薬の分野で第 3 位のシェアを占めています。その要因は、アジア太平洋地域における体外診断市場の影響力のある成長の要因となっています。
中国ではがんの罹患率と死亡率が増加しており、過去10年間でがんが同国の主な死因となっています。増加する症例の大部分は、人口増加（特に高齢者人口の急増）と社会人口動態の変化によるものです。臨床試験検査サービス組織である Q2 Solutions は、広州 KingMed Diagnostics と協力して、中国市場向けの体外診断製品およびコンパニオン診断 (CDx) を開発しました。
さらに複数のプレーヤーが、がんバイオマーカー市場の拡大に投資しています。 2018 年 8 月、イプソスのヘルスケア サービス ラインは、シンジケート化されたラボ マッピング研究と腫瘍分子診断 (MDx) モニターを開始しました。これら 2 つの研究は、中国の第 1 級都市および第 2 級都市での包括的な腫瘍バイオマーカー検査を提供します。
目次
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific In-Vitro Diagnostics Market - Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Increasing Prevalence of Chronic and Infectious Diseases
4.1.2 Growth in Point-of-Care Testing and Surge in Demand for IVD during COVID-19 Pandemic
4.2 Market Restraint
4.2.1 Insufficiency of Regulatory Frameworks and Reimbursement Policies
4.3 Market Opportunities
4.3.1 Integration of IVD with Digital Health Technologies
4.4 Future Trends
4.4.1 Increasing Demand for Personalized Medicine and Genomics
5. Asia Pacific In-Vitro Diagnostics Market - Global Market Analysis
5.1 Asia Pacific In-Vitro Diagnostics Market Revenue (US$ Mn), 2022 - 2030
6. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Product and Serices
6.1 Overview
6.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
6.3 Reagents and Kits
6.3.1 Overview
6.3.2 Reagents and Kits: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Software and Services
6.4.1 Overview
6.4.2 Software and Services: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Instruments
6.5.1 Overview
6.5.2 Instruments: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Technology
7.1 Overview
7.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
7.3 Immunoassay/ Immunochemistry
7.3.1 Overview
7.3.2 Immunoassay/ Immunochemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Clinical Chemistry
7.4.1 Overview
7.4.2 Clinical Chemistry: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Molecular Diagnostics
7.5.1 Overview
7.5.2 Molecular Diagnostics: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Microbiology
7.6.1 Overview
7.6.2 Microbiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Blood Glucose Self-Monitoring
7.7.1 Overview
7.7.2 Blood Glucose Self-Monitoring: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Coagulation and Hemostasis
7.8.1 Overview
7.8.2 Coagulation and Hemostasis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Hematology
7.9.1 Overview
7.9.2 Hematology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Urinalysis
7.10.1 Overview
7.10.2 Urinalysis: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by Application
8.1 Overview
8.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Infectious Disease
8.3.1 Overview
8.3.2 Infectious Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Diabetes
8.4.1 Overview
8.4.2 Diabetes: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Oncology
8.5.1 Overview
8.5.2 Oncology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cardiology
8.6.1 Overview
8.6.2 Cardiology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Autoimmune Diseases
8.7.1 Overview
8.7.2 Autoimmune Diseases: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Nephrology
8.8.1 Overview
8.8.2 Nephrology: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Asia Pacific In-Vitro Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Laboratories
9.4.1 Overview
9.4.2 Laboratories: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Asia Pacific In-Vitro Diagnostics Market
10.1.1 Overview
10.1.2 Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Country
10.1.2.1 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 China: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.1.4 China: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.1.5 China: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.1.6 China: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Japan: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.2.4 Japan: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.2.5 Japan: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.2.6 Japan: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.2.3 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 India: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.3.4 India: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.3.5 India: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.3.6 India: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.2.4 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.3 Australia: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.4.4 Australia: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.4.5 Australia: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.4.6 Australia: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.2.5 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.3 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.5.4 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.5.5 South Korea: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.5.6 South Korea: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
10.1.2.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Product and Services, 2020-2030 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Technology, 2020-2030 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by Application, 2020-2030 (US$ Million)
10.1.2.6.6 Rest of Asia Pacific: Asia Pacific In-Vitro Diagnostics Market, by End User, 2020-2030 (US$ Million)
11. Industry Landscape
11.1 Organic Developments
11.1.1 Overview
11.2 Inorganic Developments
11.2.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danaher Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Siemens AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Thermo Fisher Scientific Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Becton Dickinson and Co
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 bioMerieux SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Qiagen NV
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
